Literature DB >> 8823291

Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting.

M K Sinha1, I Opentanova, J P Ohannesian, J W Kolaczynski, M L Heiman, J Hale, G W Becker, R R Bowsher, T W Stephens, J F Caro.   

Abstract

Little is known about leptin's interaction with other circulating proteins which could be important for its biological effects. Sephadex G-100 gel filtration elution profiles of 125I-leptin-serum complex demonstrated 125I-leptin eluting in significant proportion associated with macromolecules. The 125I-leptin binding to circulating macromolecules was specific, reversible, and displaceable with unlabeled leptin (ED50: 0.73 +/- 0.09 nM, mean +/- SEM, n = 3). Several putative leptin binding proteins were detected by leptin-affinity chromatography of which either 80- or 100-kD proteins could be the soluble leptin receptor as approximately 10% of the bound 125I-leptin was immunoprecipitable with leptin receptor antibodies. Significantly higher (P < 0.001) proportions of total leptin circulate in the bound form in lean (46.5 +/- 6.6%) compared with obese (21.4 +/- 3.4%) subjects. In lean subjects with 21% or less body fat, 60-98% of the total leptin was in the bound form. Short-term fasting significantly decreased basal leptin levels in three lean (P < 0.0005) and three obese (P < 0.005) subjects while refeeding restored it to basal levels. The effects of fasting on free leptin levels were more pronounced in lean subjects (basal vs. 24-h fasting: 19.6 +/- 1.9 vs. 1.3 +/- 0.4 ng/ml) compared with those in obese subjects (28.3 +/- 9.8 vs. 14.7 +/- 5.3). No significant (P > 0.05) decrease was observed in bound leptin in either group. These studies suggest that in obese individuals the majority of leptin circulates in free form, presumably bioactive protein, and thus obese subjects are resistant to free leptin. In lean subjects with relatively low adipose tissue, the majority of circulating leptin is in the bound form and thus may not be available to brain receptors for its inhibitory effects on food intake both under normal and food deprivation states.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823291      PMCID: PMC507552          DOI: 10.1172/JCI118913

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain.

Authors:  J F Bazan
Journal:  Biochem Biophys Res Commun       Date:  1989-10-31       Impact factor: 3.575

Review 2.  Role of plasma proteins in the binding, distribution and metabolism of the thyroid hormones.

Authors:  J H Oppenheimer
Journal:  N Engl J Med       Date:  1968-05-23       Impact factor: 91.245

Review 3.  Insulin-like growth factor binding proteins: roles in regulating IGF physiology.

Authors:  D R Clemmons
Journal:  J Dev Physiol       Date:  1991-02

4.  Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.

Authors:  J A Symons; N C Wood; F S Di Giovine; G W Duff
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

5.  A specific growth hormone-binding protein in human plasma: initial characterization.

Authors:  G Baumann; M W Stolar; K Amburn; C P Barsano; B C DeVries
Journal:  J Clin Endocrinol Metab       Date:  1986-01       Impact factor: 5.958

Review 6.  Plasma steroid-binding proteins.

Authors:  W Rosner
Journal:  Endocrinol Metab Clin North Am       Date:  1991-12       Impact factor: 4.741

7.  Positional cloning of the mouse obese gene and its human homologue.

Authors:  Y Zhang; R Proenca; M Maffei; M Barone; L Leopold; J M Friedman
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  Identification and characterization of specific binding proteins for growth hormone in normal human sera.

Authors:  A C Herington; S Ymer; J Stevenson
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

9.  Detection of two growth hormone receptor mRNAs and primary translation products in the mouse.

Authors:  W C Smith; D I Linzer; F Talamantes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

10.  Abnormal splicing of the leptin receptor in diabetic mice.

Authors:  G H Lee; R Proenca; J M Montez; K M Carroll; J G Darvishzadeh; J I Lee; J M Friedman
Journal:  Nature       Date:  1996-02-15       Impact factor: 49.962

View more
  76 in total

1.  Postnatal changes in concentrations of free and bound leptin.

Authors:  T K Hytinantti; M Juntunen; H A Koistinen; V A Koivisto; S L Karonen; S Andersson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

2.  Modulatory role of testosterone in plasma leptin turnover in rats.

Authors:  Daniel Castrogiovanni; Mario Perelló; Rolf C Gaillard; Eduardo Spinedi
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

Review 3.  [Antipsychotic drug-induced changes in metabolism].

Authors:  Julia Engl; Alexander Tschoner; Markus Laimer; Maria Rettenbacher; W Wolfgang Fleischhacker; Josef R Patsch; Christoph Ebenbichler
Journal:  Wien Klin Wochenschr       Date:  2006-05       Impact factor: 1.704

4.  Reanalysis of parabiosis of obesity mutants in the age of leptin.

Authors:  Wenwen Zeng; Yi-Hsueh Lu; Jonah Lee; Jeffrey M Friedman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

5.  Leptin activates ATP-sensitive potassium channels in the rat insulin-secreting cell line, CRI-G1.

Authors:  J Harvey; F McKenna; P S Herson; D Spanswick; M L Ashford
Journal:  J Physiol       Date:  1997-11-01       Impact factor: 5.182

Review 6.  Regulation of circulating leptin in humans.

Authors:  B Ahrén; H Larsson; C Wilhelmsson; B Näsman; T Olsson
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 7.  Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Sanja Stojsavljević; Marija Gomerčić Palčić; Lucija Virović Jukić; Lea Smirčić Duvnjak; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

8.  Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN).

Authors:  Unab I Khan; Dan Wang; Maryfran R Sowers; Peter Mancuso; Susan A Everson-Rose; Philipp E Scherer; Rachel P Wildman
Journal:  Metabolism       Date:  2012-03-22       Impact factor: 8.694

9.  Presence of bovine leptin in edible commercial milk and infant formula.

Authors:  M Lage; R Baldelli; J P Camiña; J Rodriguez-Garci; A Peñalva; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

10.  Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis.

Authors:  Tibor Várkonyi; Levente Lázár; Attila Molvarec; Nándor Gábor Than; János Rigó; Bálint Nagy
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.